These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21125154)

  • 21. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
    Braga-Basaria M; Dobs AS; Muller DC; Carducci MA; John M; Egan J; Basaria S
    J Clin Oncol; 2006 Aug; 24(24):3979-83. PubMed ID: 16921050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome.
    Fulop T; Tessier D; Carpentier A
    Pathol Biol (Paris); 2006 Sep; 54(7):375-86. PubMed ID: 16904849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and clinical characteristics of metabolic syndrome for at-risk people in a rural community.
    Oh EG; Bang SY; Hyun SS
    Metab Syndr Relat Disord; 2009 Feb; 7(1):11-5. PubMed ID: 18759659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study.
    Gomez P; Ruilope LM; Barrios V; Navarro J; Prieto MA; Gonzalez O; Guerrero L; Zamorano MA; Filozof C;
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S194-200. PubMed ID: 17130261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis.
    Welbury RR; Thomason JM; Fitzgerald JL; Steen IN; Marshall NJ; Foster HE
    Rheumatology (Oxford); 2003 Dec; 42(12):1445-51. PubMed ID: 12810923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of transient receptor potential channels in metabolic syndrome.
    Liu D; Zhu Z; Tepel M
    Hypertens Res; 2008 Nov; 31(11):1989-95. PubMed ID: 19098369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and metabolic syndrome: potential benefit from specific nutritional components.
    Abete I; Goyenechea E; Zulet MA; Martínez JA
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21 Suppl 2():B1-15. PubMed ID: 21764273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease.
    Guarner-Lans V; Rubio-Ruiz ME; Pérez-Torres I; Baños de MacCarthy G
    Exp Gerontol; 2011 Jul; 46(7):517-23. PubMed ID: 21397002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolic consequences of childhood obesity.
    Weiss R; Caprio S
    Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):405-19. PubMed ID: 16150383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
    Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
    Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance and metabolic syndrome in the pediatric population.
    Nelson RA; Bremer AA
    Metab Syndr Relat Disord; 2010 Feb; 8(1):1-14. PubMed ID: 19943799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.